Results 111 to 120 of about 17,582 (330)

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden   +10 more
wiley   +1 more source

Comparative Study Between Orthotopic Neobladder and Ileal Conduit Diversion for Patients With Cancer Bladder After Radical Cystectomy [PDF]

open access: yesAl-Azhar International Medical Journal
Background: Following radical cystectomy, several techniques are employed for urine diversion, such as the ileal conduit, cutaneous urinary reservoir, and orthotopic neobladder.
doaj   +1 more source

Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) units

open access: yesAddiction, EarlyView.
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne   +9 more
wiley   +1 more source

Long-term effects of ileal conduit urinary diversion on upper urinary tract in bladder cancer

open access: yes, 2006
OBJECTIVES: To evaluate the functional and morphologic changes of the upper urinary tract after radical cystectomy and ileal conduit urinary diversion for bladder cancer.
홍성준   +5 more
core   +1 more source

Associations of cannabis use, tobacco use and co‐use with brain volume: A systematic review and meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer   +16 more
wiley   +1 more source

Patient‐reported outcomes for monitoring substance use treatment: A systematic review of single‐item measures

open access: yesAddiction, EarlyView.
Abstract Background and aims Measurement‐based care (MBC) is a structured approach using standardized, repeated assessments to monitor treatment progress and guide clinical decision‐making. MBC improves outcomes for substance use treatment but can be time consuming due in part to lengthy assessment tools. Single‐item, patient‐reported outcome measures (
Thomas J. Reese   +13 more
wiley   +1 more source

The psychometric properties of validated tools to assess cannabis use disorder: A systematic review and meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Aims To systematically review the evidence on the psychometric performance and accuracy of screening or diagnostic tools for cannabis use disorder. Method Systematic review and meta‐analysis which included studies conducted in clinical settings, schools, universities, community settings and population‐based surveys in multiple countries and ...
Janni Leung   +8 more
wiley   +1 more source

Hundreds of Ileal Condylitis Stones

open access: yesThe New Journal of Urology
One of the long-term complications of urinary diversion, urolithiasis, is influenced by factors such as bacterial colonization, urinary stasis, mucus, and anatomical abnormalities.
Ahmet Turhan   +3 more
doaj   +1 more source

Incontinent urinary diversion [PDF]

open access: yes, 1991
1)膀胱癌に対する膀胱全摘除術時に尿路変更として, 回腸導管を188例に, 尿管瘻を49例に行った.2)術後30日以内の死亡はなかった.3)術後の早期合併症は, 回腸導管94, 尿管瘻18, 晩期合併症は, 回腸導管85, 尿管瘻23に認められた.合併症を認めなかったのは, 回腸導管49, 尿管瘻14であった.4)回腸導管の術後早期合併症は, 創感染(29%), 消化管疾患(13%), 上部尿路疾患(12%)が多くみられ, 晩期合併症は, ストーマの異常(26%), 上部尿路疾患(14%), 肝炎(13%
古武, 敏彦   +6 more
core  

Brain reward function in young people with cannabis use disorder: A functional magnetic resonance imaging study

open access: yesAddiction, EarlyView.
Abstract Background and Aims Cannabis use disorder (CUD) affects ~50 million people globally. Neuroscientific theories suggest that a blunted neural response to non‐drug rewards is a hallmark of substance use disorders; however, this remains untested in CUD. The current study tested whether brain reward system responses to the anticipation and feedback
Martine Skumlien   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy